Dr. Jane Newburger of Harvard Medical School to receive 2024 Eugene Braunwald Academic Mentorship Award
MWG Holdings VP of Marketing, Nicole Hanratty, to Speak on Harnessing Consumer Data at MJ Unpacked in St. Louis, Missouri
Kennedy Space Center Visitor Complex joins Orlando CityPASS offering an extraordinary space adventure
ZETA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Zeta Global Holdings Corp. Dec. 4, 2024 6:39 PM ET Source: Kessler Topaz Meltzer & Check, LLP.
Lead Plaintiff Deadline on December 16, 2024 for ACHC Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm Dec. 4, 2024 3:30 PM ET Source: Kessler Topaz Meltzer & Check, LLP.
ZETA Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Zeta Global Holdings Corp. Investors of Securities Fraud Class Action Lawsuit Deadline Dec. 4, 2024 1:00 PM ET Source: Kessler Topaz Meltzer & Check, LLP.
CELH SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Celsius Holdings, Inc. Dec. 4, 2024 12:00 PM ET Source: Kessler Topaz Meltzer & Check, LLP.
Kessler Topaz Meltzer & Check, LLP Reminds PACS Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against PACS Group, Inc. (PACS) Dec. 4, 2024 11:30 AM ET Source: Kessler Topaz Meltzer & Check, LLP.
EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm Dec. 4, 2024 11:00 AM ET Source: Kessler Topaz Meltzer & Check, LLP.
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC Dec. 4, 2024 9:00 AM ET Source: Nephros, Inc.
US Nuclear Announces 3rd Quarter Financials and Launch of New Marketing Initiatives Dec. 4, 2024 8:30 AM ET Source: US Nuclear Corp
Auddia Announces Acceleration of User Retention Momentum into Q4 in Support of Subscription Revenue Growth in 2025 Dec. 4, 2024 8:05 AM ET
Avant Technologies Partner, Ainnova, Signs Pilot Program With Roche to Combat Diabetic Retinopathy Dec. 4, 2024 8:00 AM ET Source: Avant Technologies Inc
